Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$130.85 - $178.03
Next Earnings Date
May 01 2025
Next Earnings Date
May 01 2025
Latest price
Market Cap | $9.77B |
EV | $10.65B |
Shares Outstanding | 66.58M |
Beta | 0.59 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $173.17 |
P/E 2025E | 26.62x |
P/Revenue 2025E | 2.67x |
Revenue | 3.60% |
EPS | 13.30% |
Operating Cash Flow | 21.00% |
Free Cash Flow | 85.50% |
Revenue | 5.30% |
EPS | 6.20% |
Operating Cash Flow | - |
Free Cash Flow | 7.50% |
Gross Margin 2025E | 37.56% |
Net Profit Margin 2025E | 10.05% |
ROE 2025E | 13.61% |
ROCE 2024 | 15.68% |
DPS 2025E | $1.90 |
Payout Ratio 2025E | 34.17% |
Div. Yield 2025E | 1.28% |
DPS Last 3Y CAGR | 4.70% |
Price
%
1M
3M
6M
1Y
3Y
5Y
AptarGroup, Inc.
ATR
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Tanda, Stephan
Employees
13,500
Website
www.aptar.comIPO Date
1993-04-23
Headquarters
265 Exchange Drive, Suite 301, Crystal Lake, Illinois, 60014, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved